R. Gaston

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

A. Gaber, S. Busque, S. Mulgaonkar, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

in vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates

A. Ravaud, V. Coulon, N. Gualde, 2000, International journal of cancer.

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.

J. Blay, A. Ravaud, T. Philip, 1994, British Journal of Cancer.

Phase 1 Dose‐Escalation Study of CP‐690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics

W. Weimar, M. Pescovitz, D. Brennan, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Realistic Proposal—Incentives May Increase Donation—We Need Trials Now!

A. Matas, A. Reed, T. Gutmann, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Differential analysis of cyclocytidine, 1-beta-D-arabinofuranosylcytosine, and 1-beta-D-arabinofuranosyluracil by ultraviolet spectophotometry.

R. Furner, R. Gaston, L. Mellett, 1974, Journal of the National Cancer Institute.

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial

A. Ravaud, B. Bui, S. Mathoulin-Pélissier, 2003, British Journal of Cancer.